FDA com­mis­sion­er hints at car­dio-re­lat­ed la­bel ex­pan­sion for We­govy, full ap­proval for Lil­ly's new Alzheimer's drug

WASH­ING­TON — FDA Com­mis­sion­er Rob Califf took the podi­um Wednes­day af­ter­noon at the Na­tion­al Press Club, of­fer­ing up more warn­ings about mis­in­for­ma­tion lead­ing to de­clin­ing vac­cine …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER